and low platelets) or eclampsia may resemble severe disease flare. Distinguishing among these syndromes requires the expertise of rheumatologists and obstetrics-gynecology or maternal-fetal medicine physicians working together. Most information regarding pregnancy management in RMD comes from observational studies, primarily in patients with SLE and APS. There have been very few controlled trials. Data about pregnancies in rare rheumatic diseases usually derive from small case series. For these reasons, many recommendations are conditional, supported by collective experience of the Voting Panel members and patient input. Supplementary Appendix As standard good practice, we strongly suggest counseling women with RMD who are considering pregnancy regarding the improved maternal and fetal outcomes (based on many studies) associated with entering pregnancy with quiescent/low activity disease Patient participants expressed a strong desire that their physicians discuss family planning